Chapter 1. Biochemical Diagnostics for Rare Diseases Market – Scope & Methodology
1.1    Market Segmentation
1.2    Assumptions
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources
Chapter 2. Biochemical Diagnostics for Rare Diseases Market – Executive Summary
2.1    Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
2.3    COVID-19 Impact Analysis
           2.3.1    Impact during 2023 – 2030
           2.3.2    Impact on Supply – Demand
Chapter 3. Biochemical Diagnostics for Rare Diseases Market – Competition Scenario
3.1    Market Share Analysis
3.2    Product Benchmarking
3.3    Competitive Strategy & Development Scenario
3.4    Competitive Pricing Analysis
3.5    Supplier - Distributor Analysis
Chapter 4. Biochemical Diagnostics for Rare Diseases Market - Entry Scenario
4.1     Case Studies – Start-up/Thriving Companies
4.2     Regulatory Scenario - By Region
4.3    Customer Analysis
4.4     Porter's Five Force Model
           4.4.1     Bargaining Power of Suppliers
           4.4.2     Bargaining Powers of Customers
           4.4.3    Threat of New Entrants
           4.4.4    .Rivalry among Existing Players
           4.4.5    Threat of Substitutes
Chapter 5. Biochemical Diagnostics for Rare Diseases Market - Landscape
5.1     Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities 
Chapter 6. Biochemical Diagnostics for Rare Diseases Market - By Disease Type
6.1    Metabolic Disorders
6.2    Lysosomal Storage Disorders
6.3    Muscle Disorders
6.4    Immunodeficiencies
6.5    Leukodystrophies/Genetic Leukoencephalopathies
6.6    Hemoglobinopathies
6.7    Pharmacogenetics
6.8    Others
Chapter 7. Biochemical Diagnostics for Rare Diseases Market - By Diagnosis Method
7.1    Mass spectrometry
7.2    Genetic testing 
           7.2.1    PCR
           7.2.2    Next-generation sequencing (NGS)
           7.2.3    Microarrays
7.3    Enzyme assays
7.4    Immunoassays
7.5    Liquid chromatography
7.6    Spectrophotometry
7.7    Others
Chapter 8. Biochemical Diagnostics for Rare Diseases Market - By Sample Type
8.1    Dried Blood Spots (DBS)
8.2    Buccal Swab
8.3    Urine 
8.4    Cerebrospinal Fluid (CSF) 
8.5    Tissue Biopsy
8.6    Others
Chapter 9. Biochemical Diagnostics for Rare Diseases Market - By End-User
9.1    Hospitals
9.2    Diagnostic Laboratories
9.3    Research Institutions
9.4    Others
Chapter 10. Biochemical Diagnostics for Rare Diseases Market – By Region
10.1    North America
10.2    Europe
10.3    Asia-Pacific
10.4    Latin America
10.5    The Middle East
10.6    Africa
Chapter 11. Biochemical Diagnostics for Rare Diseases Market – Key Players
11.1    Thermo Fisher Scientific
11.2    HORIBA
11.3    Xylem Analytics
11.4    Kova International
11.5    ARCHIMEDlife